Learn more about Peptide Receptor Radionuclide Therapy (PRRT), how it works, where it is being used, and who is eligible for this treatment.  Join Josh Mailman, President of NorCal CarciNET; Dr. Edward M. Wolin, Director of Neuroendocrine and GI Oncology and Director of Clinicial Research at the University of Kentucky; and Dr. Erik Mittra, Clinical Assistant Professor, Department of Radiology & Nuclear Medicine at Stanford University in California, on Tuesday, October 20 at 12:00 pm, Eastern Time, for a free webinar.  This webinar is sponsored by NorCal CarciNET and the Society of Nuclear Medicine and Molecular Imaging. Click here for the webinar flyer and click here to register.